PhaseRx, Inc. (OTCPK: PZRX.Q)
Health Care · Biotechnology · US
$—
— today · — 1Y
PhaseRx, Inc. (OTCPK: PZRX.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.00.
trading between 0.00 and 0.00.
Tweenvest scores PhaseRx, Inc. across four factors: quality 31/100, value 52/100. Its strongest factor is value.
PZRX.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.19
- Dividend yield
- —
- Beta (5Y)
- 32.57
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.71M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mymetics CorporationOTCPK: MYMX | $46.00 | $— | — |
| Rebus Holdings, Inc.OTCPK: RBSH | $32.00 | $0.00 | — |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $— | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $— | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $— | — |
| Panbela Therapeutics, Inc.OTCPK: PBLA | $5.00 | $0.00 | -99.99% |
Figures last refreshed Oct 4, 2026.